| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2023 | Nov 16, 2023 | Fortress Biotech, Inc. | Officer | Buy | 95.0 | +147,058 | 14.95% | ✗ | $250K |
| Aug 11, 2023 | Aug 14, 2023 | TG THERAPEUTICS, INC. | CEO | Buy | 77.5 | +100,000 | 0.84% | ✗ | $1M |
| Feb 10, 2023 | Feb 14, 2023 | Fortress Biotech, Inc. | Officer | Buy | 92.5 | +1,197,604 | 8.84% | ✗ | $1000K |
| Dec 15, 2021 | Jan 7, 2022 | TG THERAPEUTICS, INC. | CEO | Sell | 40.0 | -723,826 | -0.91% | ✗ | $1.3M |
| Jun 26, 2019 | Jun 27, 2019 | TG THERAPEUTICS, INC. | CEO | Buy | 67.5 | +50,000 | 0.39% | ✗ | $351.8K |
| Dec 16, 2014 | Dec 18, 2014 | TG THERAPEUTICS, INC. | Officer | Sell | 37.5 | -210,618 | -2.53% | ✗ | $3.5M |
| Nov 6, 2014 | Nov 10, 2014 | Fortress Biotech, Inc. | Exec. VC - Strategic Dev. | Buy | 100.0 | +1,000,000 | 16.84% | ✗ | $1.6M |
| Dec 11, 2013 | Dec 12, 2013 | TG THERAPEUTICS, INC. | Officer | Buy | 56.3 | +10,000 | 0.13% | ✗ | $34.3K |
| Sep 10, 2012 | Sep 11, 2012 | TG THERAPEUTICS, INC. | Officer | Buy | 85.0 | +150,000 | 2.09% | ✗ | $337.5K |
| Apr 30, 2012 | May 17, 2012 | TG THERAPEUTICS, INC. | Officer | Buy | 90.0 | +1,501,500 | 40.68% | ✗ | $9.4K |